Frontiers in Immunology, 2025
Proteomics profiling of inflammatory responses to elexacaftor/tezacaftor/ivacaftor in cystic fibrosis

Ozuna H., Bojja D., Partida-Sanchez S. et al.

Journal for ImmunoTherapy of Cancer, 2025
Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial

Pakola S., Clubb J., Kudling T. et al.

Scientific Reports, 2025
Interconnections between BDH1-plasma protein-type 2 diabetes Mellitus: a mediated mendelian randomization analysis using plasma proteomics

Liu Y., Zhang Y., Wan Q.

The FASEB Journal, 2025
Novel inflammatory markers in intracerebral hemorrhage: Results from Olink proteomics analysis

Hu Z., Chen S., Zhang E. et al.

Nature Genetics, 2025
Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease

Yoshiji S., Lu T., Butler-Laporte G. et al.

CHEST Critical Care, 2025
Immunomodulation for acute respiratory distress syndrome: insights from proteomics in COVID-19

Rademaker E., Haitsma Mulier J., Drylewicz J. et al.

Pediatric Research, 2025
Distinct pro-inflammatory/pro-angiogenetic signatures distinguish children with Long COVID from controls

Buonsenso D., Cotugno N., Amodio D. et al.

British Journal of Dermatology, 2025
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)

Silverberg J., Eichenfield L., Blauvelt A. et al.

European Heart Journal, 2025
Fibroblast growth factor 5: a novel biomarker for familial hypercholesterolaemia

Baragetti A., Alieva A., Grigore L. et al.

European Heart Journal, 2025
Mosaic loss of Y chromosome and mortality after coronary angiography

Weyrich M., Zewinger S., Sarakpi T. et al.

Journal of Translational Medicine, 2025
Multi-omics analysis reveals novel causal pathways in psoriasis pathogenesis

Guo H., Gao J., Gong L. et al.

European Journal of Preventive Cardiology, 2025
Fibroblast growth factor 23 and outcomes of atrial fibrillation: from clinical association to genetic evidence

Li J., Lai Y., Jiang C. et al.

Biomolecules, 2025
A Genetic and Environmental Analysis of Inflammatory Factors in Chronic Widespread Pain Using the TwinsUK Cohort

Cherny S., Livshits G., Williams F.

Hepatology International, 2025
Non-canonical Wnt signaling pathway activated NFATC3 promotes GDF15 expression in MASH: prospective analyses of UK biobank proteomic data

Wang H., Xu X., Shi L. et al.

European Journal of Heart Failure, 2025
Circulating growth differentiation factor‐15 levels are associated with early echocardiographic signs of diastolic function impairment in the STANISLAS cohort: A 20‐year follow‐up study

Monzo L., Xhaard C., Ferreira J. et al.

Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2025
Unraveling the impact of blood RANKL and OPG levels on Alzheimer's disease: Independent of bone mineral density and inflammation

Guo X., Shi W., Lu J. et al.

Clinical Proteomics, 2025
ARTN and CCL23 predicted chemosensitivity in acute myeloid leukemia: an Olink® proteomics approach

Wu T., Hsiao T., Chen C. et al.

American Journal of Physiology-Heart and Circulatory Physiology, 2025
Chemerin is a new sex-specific target in aortic stenosis concomitant with diabetes regulated by the aldosterone/mineralocorticoid receptor axis

Goñi-Olóriz M., Garaikoetxea Zubillaga M., San Ildefonso-García S. et al.

Cell, 2025
Systems-level immunomonitoring in children with solid tumors to enable precision medicine

Chen Q., Zhao B., Tan Z. et al.

Archives of Gerontology and Geriatrics, 2025
Causal relationship between gut microbiota and ageing: A multi-omics Mendelian randomization study

Zhang G., Lu Y., Wang Z. et al.